Clinical Trial Update: A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tislelizumab in combination with chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer has completed and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-10-17